vs
Side-by-side financial comparison of ONESPAWORLD HOLDINGS Ltd (OSW) and Piedmont Realty Trust, Inc. (PDM). Click either name above to swap in a different company.
ONESPAWORLD HOLDINGS Ltd is the larger business by last-quarter revenue ($242.1M vs $143.3M, roughly 1.7× Piedmont Realty Trust, Inc.). ONESPAWORLD HOLDINGS Ltd runs the higher net margin — 5.0% vs -31.4%, a 36.4% gap on every dollar of revenue. On growth, ONESPAWORLD HOLDINGS Ltd posted the faster year-over-year revenue change (11.5% vs 0.4%). Over the past eight quarters, ONESPAWORLD HOLDINGS Ltd's revenue compounded faster (7.1% CAGR vs 0.0%).
Piedmont Realty Trust, Inc. is a publicly traded real estate investment trust (REIT) that owns, operates, and invests in high-quality office properties primarily located in high-growth metropolitan areas across the United States. It serves corporate tenants across multiple industry sectors including technology, professional services, and healthcare, and pursues stable long-term returns for stakeholders via strategic property management and portfolio optimization.
OSW vs PDM — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $242.1M | $143.3M |
| Net Profit | $12.1M | $-45.0M |
| Gross Margin | — | — |
| Operating Margin | 6.8% | — |
| Net Margin | 5.0% | -31.4% |
| Revenue YoY | 11.5% | 0.4% |
| Net Profit YoY | -16.2% | -27.9% |
| EPS (diluted) | $0.12 | $-0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $143.3M | ||
| Q4 25 | $242.1M | $142.9M | ||
| Q3 25 | $258.5M | $139.2M | ||
| Q2 25 | $240.7M | $140.3M | ||
| Q1 25 | $219.6M | $142.7M | ||
| Q4 24 | $217.2M | $143.2M | ||
| Q3 24 | $241.7M | $139.3M | ||
| Q2 24 | $224.9M | $143.3M |
| Q1 26 | — | $-45.0M | ||
| Q4 25 | $12.1M | $-43.2M | ||
| Q3 25 | $24.3M | $-13.5M | ||
| Q2 25 | $19.9M | $-16.8M | ||
| Q1 25 | $15.3M | $-10.1M | ||
| Q4 24 | $14.4M | $-30.0M | ||
| Q3 24 | $21.6M | $-11.5M | ||
| Q2 24 | $15.8M | $-9.8M |
| Q1 26 | — | — | ||
| Q4 25 | 6.8% | — | ||
| Q3 25 | 10.2% | — | ||
| Q2 25 | 9.2% | — | ||
| Q1 25 | 7.7% | — | ||
| Q4 24 | 7.9% | — | ||
| Q3 24 | 10.3% | — | ||
| Q2 24 | 8.4% | — |
| Q1 26 | — | -31.4% | ||
| Q4 25 | 5.0% | -30.3% | ||
| Q3 25 | 9.4% | -9.7% | ||
| Q2 25 | 8.3% | -12.0% | ||
| Q1 25 | 7.0% | -7.1% | ||
| Q4 24 | 6.6% | -20.9% | ||
| Q3 24 | 8.9% | -8.3% | ||
| Q2 24 | 7.0% | -6.8% |
| Q1 26 | — | $-0.10 | ||
| Q4 25 | $0.12 | $-0.34 | ||
| Q3 25 | $0.23 | $-0.11 | ||
| Q2 25 | $0.19 | $-0.14 | ||
| Q1 25 | $0.15 | $-0.08 | ||
| Q4 24 | $0.13 | $-0.25 | ||
| Q3 24 | $0.20 | $-0.09 | ||
| Q2 24 | $0.15 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $16.3M | $2.3M |
| Total DebtLower is stronger | $84.0M | — |
| Stockholders' EquityBook value | $542.6M | $1.5B |
| Total Assets | $707.1M | $4.0B |
| Debt / EquityLower = less leverage | 0.15× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $2.3M | ||
| Q4 25 | $16.3M | $731.0K | ||
| Q3 25 | $29.6M | $3.0M | ||
| Q2 25 | $35.0M | $3.3M | ||
| Q1 25 | $22.6M | $2.9M | ||
| Q4 24 | $57.4M | $109.6M | ||
| Q3 24 | $48.8M | $133.6M | ||
| Q2 24 | $62.5M | $138.5M |
| Q1 26 | — | — | ||
| Q4 25 | $84.0M | $2.2B | ||
| Q3 25 | $85.2M | $2.2B | ||
| Q2 25 | $96.2M | $2.2B | ||
| Q1 25 | $97.4M | $2.2B | ||
| Q4 24 | $98.6M | $2.2B | ||
| Q3 24 | $98.7M | $2.2B | ||
| Q2 24 | $123.8M | $2.2B |
| Q1 26 | — | $1.5B | ||
| Q4 25 | $542.6M | $1.5B | ||
| Q3 25 | $552.8M | $1.5B | ||
| Q2 25 | $548.3M | $1.5B | ||
| Q1 25 | $530.6M | $1.6B | ||
| Q4 24 | $554.5M | $1.6B | ||
| Q3 24 | $540.1M | $1.6B | ||
| Q2 24 | $532.7M | $1.7B |
| Q1 26 | — | $4.0B | ||
| Q4 25 | $707.1M | $4.0B | ||
| Q3 25 | $732.6M | $4.0B | ||
| Q2 25 | $731.8M | $4.0B | ||
| Q1 25 | $708.7M | $4.0B | ||
| Q4 24 | $746.4M | $4.1B | ||
| Q3 24 | $734.0M | $4.1B | ||
| Q2 24 | $756.8M | $4.2B |
| Q1 26 | — | — | ||
| Q4 25 | 0.15× | 1.49× | ||
| Q3 25 | 0.15× | 1.43× | ||
| Q2 25 | 0.18× | 1.41× | ||
| Q1 25 | 0.18× | 1.40× | ||
| Q4 24 | 0.18× | 1.40× | ||
| Q3 24 | 0.18× | 1.36× | ||
| Q2 24 | 0.23× | 1.34× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $20.0M | — |
| Free Cash FlowOCF − Capex | $14.9M | — |
| FCF MarginFCF / Revenue | 6.2% | — |
| Capex IntensityCapex / Revenue | 2.1% | 110.3% |
| Cash ConversionOCF / Net Profit | 1.65× | — |
| TTM Free Cash FlowTrailing 4 quarters | $68.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $20.0M | $140.6M | ||
| Q3 25 | $33.2M | $35.8M | ||
| Q2 25 | $20.3M | $50.1M | ||
| Q1 25 | $10.1M | $3.7M | ||
| Q4 24 | $16.6M | $198.1M | ||
| Q3 24 | $28.6M | $42.9M | ||
| Q2 24 | $18.7M | $66.8M |
| Q1 26 | — | — | ||
| Q4 25 | $14.9M | — | ||
| Q3 25 | $27.6M | — | ||
| Q2 25 | $17.6M | — | ||
| Q1 25 | $8.4M | — | ||
| Q4 24 | $13.2M | — | ||
| Q3 24 | $27.5M | — | ||
| Q2 24 | $17.6M | — |
| Q1 26 | — | — | ||
| Q4 25 | 6.2% | — | ||
| Q3 25 | 10.7% | — | ||
| Q2 25 | 7.3% | — | ||
| Q1 25 | 3.8% | — | ||
| Q4 24 | 6.1% | — | ||
| Q3 24 | 11.4% | — | ||
| Q2 24 | 7.8% | — |
| Q1 26 | — | 110.3% | ||
| Q4 25 | 2.1% | — | ||
| Q3 25 | 2.2% | — | ||
| Q2 25 | 1.1% | — | ||
| Q1 25 | 0.8% | — | ||
| Q4 24 | 1.5% | — | ||
| Q3 24 | 0.5% | — | ||
| Q2 24 | 0.5% | — |
| Q1 26 | — | — | ||
| Q4 25 | 1.65× | — | ||
| Q3 25 | 1.36× | — | ||
| Q2 25 | 1.02× | — | ||
| Q1 25 | 0.66× | — | ||
| Q4 24 | 1.15× | — | ||
| Q3 24 | 1.33× | — | ||
| Q2 24 | 1.19× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OSW
| Services | $197.3M | 82% |
| Products | $44.8M | 18% |
PDM
Segment breakdown not available.
